tiprankstipranks
Advertisement
Advertisement

CNTX Stock Latest News

Advancing Bispecific T‑Cell Engager Pipeline and Regulatory Milestones Underpin Buy Rating on Context
RatingsAdvancing Bispecific T‑Cell Engager Pipeline and Regulatory Milestones Underpin Buy Rating on Context
10d ago
CNTX
3 Best Stocks to Buy Today, 4/3/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 4/3/2026, According to Top Analysts
10d ago
AVNW
CNTX
Context Therapeutics Gains FDA Fast Track for CTIM-76
PremiumCompany Announcements
Context Therapeutics Gains FDA Fast Track for CTIM-76
11d ago
8K
CNTX
Context Therapeutics granted Fast Track Designation to CTIM-76 by FDA
PremiumThe Fly
Context Therapeutics granted Fast Track Designation to CTIM-76 by FDA
11d ago
CNTX
Context Therapeutics: Advancing T‑Cell Engager Pipeline and De‑Risked Cash Runway Support a Buy Rating
PremiumRatings
Context Therapeutics: Advancing T‑Cell Engager Pipeline and De‑Risked Cash Runway Support a Buy Rating
20d ago
CNTX
Context Therapeutics price target raised to $7 from $4 at Piper Sandler
PremiumThe FlyContext Therapeutics price target raised to $7 from $4 at Piper Sandler
20d ago
CNTX
Context Therapeutics Highlights Evolving T Cell Engager Pipeline
Premium
Company Announcements
Context Therapeutics Highlights Evolving T Cell Engager Pipeline
21d ago
8K
CNTX
CNTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CNTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
21d ago
CNTX
Context Therapeutics Adopts Shareholder-Friendly Board Governance Changes
PremiumCompany Announcements
Context Therapeutics Adopts Shareholder-Friendly Board Governance Changes
1M ago
8K
CNTX
Context Therapeutics Reaches Governance Settlement, Plans Annual Elections
PremiumCompany Announcements
Context Therapeutics Reaches Governance Settlement, Plans Annual Elections
1M ago
8K
CNTX
Context Therapeutics Highlights T Cell Engager Pipeline Strategy
PremiumCompany Announcements
Context Therapeutics Highlights T Cell Engager Pipeline Strategy
3M ago
8K
CNTX
Context Therapeutics initiated with a Buy at JonesResearch
PremiumThe Fly
Context Therapeutics initiated with a Buy at JonesResearch
4M ago
CNTX
Buy Rating for Context Therapeutics: Strong Financials and Promising Clinical Developments
PremiumRatingsBuy Rating for Context Therapeutics: Strong Financials and Promising Clinical Developments
5M ago
CNTX
Context Therapeutics highlights CT-95, CT-202 programs at SITC meeting
Premium
The Fly
Context Therapeutics highlights CT-95, CT-202 programs at SITC meeting
5M ago
CNTX
Context Therapeutics price target raised to $5 from $4 at H.C. Wainwright
Premium
The Fly
Context Therapeutics price target raised to $5 from $4 at H.C. Wainwright
5M ago
CNTX
Positive Outlook for Context Therapeutics: Promising Developments in CTIM-76 Study Justify Buy Rating
PremiumRatings
Positive Outlook for Context Therapeutics: Promising Developments in CTIM-76 Study Justify Buy Rating
5M ago
CNTX
Context Therapeutics Reports Improved Quarterly Results
PremiumCompany Announcements
Context Therapeutics Reports Improved Quarterly Results
5M ago
CNTX
Context Therapeutics reports Q3 EPS (10c), consensus (9c)
PremiumThe Fly
Context Therapeutics reports Q3 EPS (10c), consensus (9c)
5M ago
CNTX
Context Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Context Therapeutics Reports Q3 2025 Financial Results
5M ago
8K
CNTX
Context Therapeutics Advances in Cancer Treatment with CTIM-76 Study
PremiumCompany AnnouncementsContext Therapeutics Advances in Cancer Treatment with CTIM-76 Study
6M ago
CNTX
Context Therapeutics’ CT-95 Study: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Context Therapeutics’ CT-95 Study: A Potential Game-Changer in Cancer Treatment
6M ago
CNTX
Context Therapeutics Amends Sales Agreement with Leerink
Premium
Company Announcements
Context Therapeutics Amends Sales Agreement with Leerink
6M ago
8K
CNTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >